NxStage

NxStage Medical, Inc. (/ˈnɛkˌsteɪdʒ/ NEK-stayj[2]) is an American company that develops, manufactures, and markets systems for the treatment of chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. System One, a portable hemodialysis system, is the company's primary product.[1]

NxStage Medical, Inc.
Company typeSubsidiary
IndustryMedical devices
FoundedDecember 1998 (1998-12)
FounderC. David Finch, Jr., MD and Jeffrey H. Burbank
Headquarters
Lawrence, Massachusetts
,
U.S.
ProductsSystem One
Revenue $393 million (2017)
-$14 million (2017)
Total assets $325 million (2017)
Total equity $213 million (2017)
Number of employees
3,800 (2017)
ParentFresenius Medical Care
Websitewww.nxstage.com
Footnotes / references
[1]

History

The company was founded by C. David Finch, Jr., MD[3] and Jeffrey H. Burbank in December 1998.[4]

In 2003, the company launched System One in the critical care market. It received Food and Drug Administration clearance for home hemodialysis in June 2005.[5]

In October 2005, the company became a public company via an initial public offering.[6]

On November 2, 2005, the company received the Nixon Peabody/Smith&Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC).[7]

In December 2014, the company received Food and Drug Administration clearance for System One to be used overnight while patients are sleeping.[8]

In August 2017, the company received Food and Drug Administration clearance for System One for solo home hemodialysis, without a care partner, during waking hours.[9]

In February 2019, the company was acquired by Fresenius Medical Care.[10][11]

References
  1. "NxStage Medical, Inc. 2017 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
  2. "https://www.youtube.com/watch?v=ODLYNrbJf5I". YouTube. October 27, 2023. Retrieved 1 June 2024. {{cite web}}: External link in |title= (help)
  3. Who, Marquis Who's (2014-01-10). "C. David Finch Jr. MD". Elite American Physicians. Retrieved 2019-10-24.
  4. "Company Overview of NxStage Kidney Care, Inc". Bloomberg L.P. 15 July 2023.
  5. "NxStage Medical Receives FDA Clearance for Home Hemodialysis System" (Press release). Business Wire. June 29, 2005.
  6. "NxStage Medical rolls out lower-priced IPO". American City Business Journals. October 24, 2005.
  7. "MassMEDIC Honors NxStage Medical with Innovation Award for Portable Home Hemodialysis System" (Press release). Business Wire. November 2, 2005.
  8. Seiffert, Don (December 29, 2014). "NxStage nabs first-ever FDA approval for overnight home hemodialysis". American City Business Journals.
  9. "NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™" (Press release). PR Newswire. August 28, 2017.
  10. BANNOW, TARA (February 26, 2019). "Fresenius Medical Care closes $2 billion NxStage acquisition". Modern Healthcare.
  11. "Fresenius Medical Care completes acquisition of NxStage Medical" (Press release). PR Newswire. February 26, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.